The significance of transfusion in the past as a risk for current hepatitis B and hepatitis C infection: A study in endoscopy patients

Transfusion

Volumn 45, Issue 5, 2005, Pages 807-813

  Tawk, Hani M ^b   Vickery, Karen ^b   Bisset, Linda ^b   Lo, Sing Kai ^b   Cossart, Yvonne E ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; BLOOD SAMPLING; BLOOD TRANSFUSION; COMPUTER PROGRAM; ENDOSCOPY; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL INFECTION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RISK FACTOR; SCREENING; VIRUS TRANSMISSION;

ADULT; BLOOD TRANSFUSION; ENDOSCOPY; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW SOUTH WALES; PREVALENCE; RISK FACTORS;

EID: 18544382995     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.04317.x     Document Type: Article

References (13)

1. Seed CR, Cheng A, Ismay SL, et al. Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT. Transfusion 2002;42:1365-72.
2. Seeff LB, Hollinger FB, Alter HJ, et al. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a National Heart, Lung, and Blood Institute collaborative study. Hepatology 2001;33:455-63.
3. Hall AJ, Winter PD, Wright R. Mortality of hepatitis B positive blood donors in England and Wales. Lancet 1985;1:91-3.
4. Mahl MA, Sugg U. [Hepatitis after blood transfusion in inpatients. Post-transfusion hepatitis, or infection of other etiology?] Deutsche Med Wochenschrift 2000;125:211-5.
5. Holland PV. Post-transfusion hepatitis, current risks and causes. Vox Sang 1998;74(Suppl 2):135-41.
6. Laperche S. [Practical repercussions of 3 years of experience of national hemovigilance on the subject of viral complications]. Transfus Clin Biol 1998;5:211-8.
7. Chang TT, Young KC, Yang YJ, et al. Incidence of post-transfusion hepatitis in Taiwan before and after introduction of anti-HCV testing. Liver 1996;16:201-6.
8. Ruzzenenti MR, De Luigi MC, Bruni R, et al. PCR testing for HCV in anti-HCV negative blood donors involved in the so called HCV positive post-transfusion hepatitis. Transfus Sci 2000;22:161-4.
9. Esteban JI, Gomez J, Martell M, et al. Transmission of hepatitis C virus by a cardiac surgeon. [see comment]. N Engl J Med 1996;334:555-60.
10. Ismay SL, Fellows A, Keller A, et al. Post-transfusion hepatitis revisited. Med J Australia 1995;163:74-7.
11. Nelson M, Cooke B. The incidence of Australia antigen in blood donors and in certain high-risk patient populations. Med J Australia 1971;1:950-4.
12. Ballard AL, Boxall EH. Assessing the infectivity of hepatitis B carriers [erratum appears in Commun Dis Public Health 2000;3:69]. Communicable Dis Public Health 1999;2:178-83.
13. Hyland CA, Kearns S, Young IF, et al. Predictive markers for hepatitis C antibody ELISA specificity in Australian blood donors. Transfus Med 1992;2 (3):207-13.